ENEMA KLEEN ENEMA RADI ENEMA RAPID ENEMA ENERVIN GINGILACER INSTANT ENEMA VIFER PRIME ENEMA REVERZ RANEMA NUTRIFLEX® ORNITATE NUTRIFLEX LIPID NUTRIFLEX LIPID NUTRIFLEX LIPID

Dose: 800 mg
Single Dose: 800 (800)
Frequency: 24 hourly
Route: PO
Instructions:

Dose: 30 to 45 mg/kg
Single Dose: 38 (37.5)
Frequency: As recommended.
Route: Oral
Instructions: As required

Dose: 53.33 mg/kg
Single Dose: 53 (53.33)
Frequency: As recommended.
Route: Oral
Instructions: As required

belongs to Sodium Salt. It belongs to Laxatives pharmacological group on the basis of mechanism of action and also classified in Electrolyte Supplement Oral, Laxative pharmacological group.The Molecular Weight of Sodium Phosphate is 164.00. It is weakly alkaline drug, 3.33% solution of the drug is isotonic.

Sodium Phosphate is contraindicated in conditions like Hypocalcaemia,Hypernatremia,Hyperphosphataemia.

The signs and symptoms that are produced after the acute overdosage of Sodium Phosphate include Effect on hemopoietic system.The symptomatic adverse reactions produced by Sodium Phosphate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Phosphorus intoxication.

Sodium Phosphate is primarily indicated in conditions like Constipation, Electrolyte disorder, Hypophosphataemia.

Sodium Phosphate is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementHydrochlorothiazideShould not be use concurrently without doctors prescription.PimozideShould not be use concurrently without doctors prescription.Procainamide (HCl)Should not be use concurrently without doctors prescription.QuinidineShould not be use concurrently without doctors prescription.SparfloxacinShould not be use concurrently without doctors prescription.Technetium Tc-99m OxidronateSaturation of bone binding sites by phosphorus ions in Sodium Phosphatemay cause decreased bone uptake of technetium Tc 99m oxidronate. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Drug should not be given to Paediatrics, Cardiac / Hypertensive Patients, and patients suffering from Kidney dysfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Syrup, enema, paste Store in a well closed container, at room temperature, Between 15°C-30°C. Protect from Sunlight, Moisture and Heat.

Sodium phosphate should be used with caution in patients with renal (kidney) impairment, cirrhosis, cardiac failure and other sodium retaining states. Caution must be exercised in the administration of parenteral fluids, especially those containing sodium ions, to patients receiving corticosteroids or corticotropin. Do not administer unless solution is clear and seal is intact. Discard unused portion